Acorah Software Products - Accounts Production 16.2.850 false true false true No description of principal activity 1 April 2024 31 March 2025 31 March 2025 15587875 Dr Edward Gomm Dr Lauren Anderson iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15587875 2024-03-31 15587875 2025-03-31 15587875 2024-04-01 2025-03-31 15587875 frs-core:CurrentFinancialInstruments 2025-03-31 15587875 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 15587875 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 15587875 frs-bus:Micro-entities 2024-04-01 2025-03-31 15587875 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 15587875 frs-bus:Director1 2024-04-01 2025-03-31 15587875 frs-bus:Director2 2024-04-01 2025-03-31
Registered number: 15587875
Burghurst Medical Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2025
Sharpe Medical Accounting Ltd
Balance Sheet
Registered number: 15587875
2025
£
Fixed assets 5,587
Current assets 11,959
Creditors: Amounts Falling Due Within One Year (2,401 )
NET CURRENT ASSETS 9,558
TOTAL ASSETS LESS CURRENT LIABILITIES 15,145
Accruals and deferred income (900 )
NET ASSETS 14,245
CAPITAL AND RESERVES 14,245

Notes

1. General Information
Burghurst Medical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15587875 . The registered office is Normanby Gateway, Lysaghts Way, Scunthorpe, DN15 9YG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2
2
Page 0
Page 1
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Edward Gomm
Director
Dr Lauren Anderson
Director
08/04/2025